Of note, KLK4 stimulates protease-activated receptors −1 and −2 which are also overexpressed in prostate cancer, resulting in cytoskeletal remodelling and increased cell migration and proliferation [12], [13], [14]. Here, KLK4 is linked to prostate carcinoma.